Stroke Decision-Support Software Gets US Approval
While US FDA works on a new guidance for clinical decision support software, the agency has OK'd the de novo application for Viz.AI Contact, a software tool to help detect early signs of strokes.
You may also be interested in...
Medtronic will distribute Viz.ai’s artificial intelligence system for detection and triage of large vessel occlusions in the US alongside Medtronic's Solitaire stent-retrievers for revascularization of occluded blood vessels in the brain.
US FDA dropped three big digital-health guidances related to medical software as part of its initiative to help to streamline a path to market for a sector that is "increasingly embraced" by the health system and needs regulatory certainty, according to agency. But initial industry reaction to perhaps the most highly anticipated of the document, on clinical-decision-support software, is somewhat critical.
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.